| Dr Arvind Randhawa, MD | |
|
590 Court St, Cheshire Medical Center- Dhk, Keene, NH 03431-1719 | |
| (603) 354-5400 | |
| Not Available |
| Full Name | Dr Arvind Randhawa |
|---|---|
| Gender | Female |
| Speciality | Hematology/oncology |
| Experience | 16 Years |
| Location | 590 Court St, Keene, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326203712 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 16771 (New Hampshire) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cheshire Medical Center | Keene, NH | Hospital |
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cheshire Medical Center | 1456260165 | 155 |
| Dartmouth-hitchcock Clinic | 4183537509 | 1139 |
News Archive
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Medical technology developer Atomo Diagnostics and market leading diagnostic company BBI Solutions have entered into an agreement to commercialise Atomo's award winning, integrated rapid blood test platform, AtomoRapid.
With the retreat of the Islamist extremist group al-Shabab out of the Somali capital of Mogadishu, where famine is threatening the lives of hundreds of thousands of people, "the U.N.-backed peacekeeping force can and should be quickly expanded," according to Somalia's prime minister and the U.N. envoy to the nation, in order to "allow the force to move out from the capital to secure routes for aid," a Washington Post editorial states.
Physicians should be aware of the need to reduce the dose of sulphonylureas when adding dipeptidyl peptidase-4 inhibitor treatment in patients with Type 2 diabetes, say the authors of a meta-analysis.
› Verified 9 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Medical technology developer Atomo Diagnostics and market leading diagnostic company BBI Solutions have entered into an agreement to commercialise Atomo's award winning, integrated rapid blood test platform, AtomoRapid.
With the retreat of the Islamist extremist group al-Shabab out of the Somali capital of Mogadishu, where famine is threatening the lives of hundreds of thousands of people, "the U.N.-backed peacekeeping force can and should be quickly expanded," according to Somalia's prime minister and the U.N. envoy to the nation, in order to "allow the force to move out from the capital to secure routes for aid," a Washington Post editorial states.
Physicians should be aware of the need to reduce the dose of sulphonylureas when adding dipeptidyl peptidase-4 inhibitor treatment in patients with Type 2 diabetes, say the authors of a meta-analysis.
› Verified 9 days ago
| Entity Name | Cheshire Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093803397 PECOS PAC ID: 1456260165 Enrollment ID: O20070913000090 |
News Archive
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Medical technology developer Atomo Diagnostics and market leading diagnostic company BBI Solutions have entered into an agreement to commercialise Atomo's award winning, integrated rapid blood test platform, AtomoRapid.
With the retreat of the Islamist extremist group al-Shabab out of the Somali capital of Mogadishu, where famine is threatening the lives of hundreds of thousands of people, "the U.N.-backed peacekeeping force can and should be quickly expanded," according to Somalia's prime minister and the U.N. envoy to the nation, in order to "allow the force to move out from the capital to secure routes for aid," a Washington Post editorial states.
Physicians should be aware of the need to reduce the dose of sulphonylureas when adding dipeptidyl peptidase-4 inhibitor treatment in patients with Type 2 diabetes, say the authors of a meta-analysis.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arvind Randhawa, MD 590 Court Street, Cheshire Medical Center-dhk, Keene, NH 03431 Ph: (603) 354-5400 | Dr Arvind Randhawa, MD 590 Court St, Cheshire Medical Center- Dhk, Keene, NH 03431-1719 Ph: (603) 354-5400 |
News Archive
Stroke and myocardial infarction (MI) are a significant cause of death and disability worldwide. However, over the past several decades because of advances in medicines (thrombolytic agents, antiplatelet drugs, beta blockers, and angiotensin converting enzyme inhibitors) and approaches to restore tissue perfusion (percutaneous coronary intervention and cardiopulmonary bypass), the mortality of MI has declined dramatically.
Medical technology developer Atomo Diagnostics and market leading diagnostic company BBI Solutions have entered into an agreement to commercialise Atomo's award winning, integrated rapid blood test platform, AtomoRapid.
With the retreat of the Islamist extremist group al-Shabab out of the Somali capital of Mogadishu, where famine is threatening the lives of hundreds of thousands of people, "the U.N.-backed peacekeeping force can and should be quickly expanded," according to Somalia's prime minister and the U.N. envoy to the nation, in order to "allow the force to move out from the capital to secure routes for aid," a Washington Post editorial states.
Physicians should be aware of the need to reduce the dose of sulphonylureas when adding dipeptidyl peptidase-4 inhibitor treatment in patients with Type 2 diabetes, say the authors of a meta-analysis.
› Verified 9 days ago
Dr. John G Schlegelmilch, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5450 | |
Dr. Sherry Ann Guardiano, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5454 | |
Dr. Roy Rajan, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5400 | |
Daniel L Rath, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5400 Fax: 603-354-5429 | |
Ethan Karle, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 580 Court St, Keene, NH 03431 Phone: 603-354-5400 | |
Dr. Steven Sigurd Larmon, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 590 Court St, Keene, NH 03431 Phone: 603-354-5454 | |
Dr. Andrew C Gorske, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 590 Court St, Dartmouth Hitchcock - Gastroenterology, Keene, NH 03431 Phone: 603-354-6534 |